Grant: Engage Grants Program
York University
$24,994.00
A computational modelling framework for identifying smart vaccination strategies
EF 2015-16
Résumé
Medicago, a clinical-stage biopharmaceutical company, has developed a very innovative production method, which has the potential to enable the development of a vaccine for testing within 3 weeks of the identification of genetic sequences from an influenza strain, allowing for large-scale vaccination of the population very early during an outbreak. The company would like to know how many doses of vaccine is required and what distribution strategies should be used to maximize population-wide benefits of vaccination in the event of an influenza pandemic. We will apply an agent-based modelling approach to incorporate information on population profiles; health indicators; disease characteristics; and novel vaccine technology production and effectiveness parameters in order to determine the required number of vaccine doses and distribution rates
under constraints of vaccine manufacturing capacity and delivery. We will communicate the outcomes of this project with Medicago, which will enable them to project and improve Medicago's vaccine production capacity, so that effective communications can take place between Medicago and its customers worldwide. In addition to mitigating the negative effects of a pandemic on the Canadian economy, Medicago will use this technology to improve its market share and to become more competitive nationally and internationally. It will thereby contribute to the Canadian economy, and as this technology improves, it will provide opportunities for job creation and growth within Canada. This project provides an excellent opportunity for HQP trainees to leverage cutting edge techniques and methodologies for performing world-class research, but also to gain off-campus industrial experience involving applied-driven problems.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
491357-2015
Name nom
Heffernan, Jane
Department département
Mathematics and Statistics
Organization id
38
Institution établissement
York University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
24994
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
2960
Research subject group en
Applied mathematics
Research subject group fr
Mathématiques appliquées
Research subject en
Mathematical modelling
Research subject fr
Modélisation mathématique
Partie
1
Nb partie
1
Application title
A computational modelling framework for identifying smart vaccination strategies
Keyword
NSERC
Application summary
Medicago, a clinical-stage biopharmaceutical company, has developed a very innovative production method, which has the potential to enable the development of a vaccine for testing within 3 weeks of the identification of genetic sequences from an influenza strain, allowing for large-scale vaccination of the population very early during an outbreak. The company would like to know how many doses of vaccine is required and what distribution strategies should be used to maximize population-wide benefits of vaccination in the event of an influenza pandemic. We will apply an agent-based modelling approach to incorporate information on population profiles; health indicators; disease characteristics; and novel vaccine technology production and effectiveness parameters in order to determine the required number of vaccine doses and distribution rates
under constraints of vaccine manufacturing capacity and delivery. We will communicate the outcomes of this project with Medicago, which will enable them to project and improve Medicago's vaccine production capacity, so that effective communications can take place between Medicago and its customers worldwide. In addition to mitigating the negative effects of a pandemic on the Canadian economy, Medicago will use this technology to improve its market share and to become more competitive nationally and internationally. It will thereby contribute to the Canadian economy, and as this technology improves, it will provide opportunities for job creation and growth within Canada. This project provides an excellent opportunity for HQP trainees to leverage cutting edge techniques and methodologies for performing world-class research, but also to gain off-campus industrial experience involving applied-driven problems.